NAGE NASDAQ
Niagen Bioscience Inc
1W: -5.7%
1M: -3.8%
3M: -33.7%
YTD: -47.4%
1Y: -64.7%
3Y: +105.6%
5Y: -64.1%
$3.29
+0.06 (+1.86%)
Weekly Expected Move ±7.9%
$3
$3
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$262.0M
52W Range3.12-11.29
Volume517,618
Avg Volume857,319
Beta2.08
Dividend—
Analyst Ratings
Company Info
CEORobert N. Fried
Employees117
SectorHealthcare
IndustryBiotechnology
IPO Date2015-06-24
Websiteniagenbioscience.com
10900 Wilshire Blvd, Suite 600
Los Angeles, CA 90024
US
Los Angeles, CA 90024
US
310 388 6706
About Niagen Bioscience Inc
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Latest News
Armata Pharmaceuticals (ARMP) Stock Jumps 12.2%: Will It Continue to Soar?
Implied Volatility Surging for Niagen Bioscience Stock Options
Niagen Bioscience Inc. (NAGE) Renames Research Program Amid Focus in Advancing NAD+ Applications
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Niagen Bioscience reaffirms 10%-15% 2026 growth outlook while increasing marketing spend expectations
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lopez Carlos Luis | A-Award | 2,314 | $2.71 | 2026-06-30 |
| Pamir Ozan | A-Award | 4,255 | $2.71 | 2026-06-30 |
| Fried Robert N | A-Award | 1,106 | $2.71 | 2026-06-30 |
| Patrick Kristin | A-Award | 31,746 | $3.45 | 2026-06-24 |
| Shahbazi Hamed | A-Award | 31,746 | $3.45 | 2026-06-24 |